Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/10390
DC FieldValueLanguage
dc.contributor.authorJovanovska Aleksandraen_US
dc.contributor.authorKata Martinovaen_US
dc.contributor.authorSvetlana Kochevaen_US
dc.contributor.authorTrajkova-Antevska Zoricaen_US
dc.contributor.authorConevska-Jovanova Biljanaen_US
dc.contributor.authorIrina Panovska-Stavridisen_US
dc.contributor.authorSvetlana Stankovikjen_US
dc.contributor.authorSanja Trajkovaen_US
dc.contributor.authorAleksandar Dimovskien_US
dc.date.accessioned2021-02-26T13:00:53Z-
dc.date.available2021-02-26T13:00:53Z-
dc.date.issued2019-09-
dc.identifier.urihttp://hdl.handle.net/20.500.12188/10390-
dc.language.isoenen_US
dc.publisherID Design/Scientific Foundation SPIROSKIen_US
dc.relation.ispartofOpen Access Macedonian Journal of Medical Sciencesen_US
dc.subjectacute lymphoblastic leukemiaen_US
dc.subjectminimal residual diseaseen_US
dc.subjectremissonen_US
dc.titleClinical significance of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemiaen_US
dc.typeArticleen_US
item.fulltextWith Fulltext-
item.grantfulltextopen-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Medicine-
crisitem.author.deptFaculty of Pharmacy-
crisitem.author.deptFaculty of Medicine-
Appears in Collections:Faculty of Medicine: Journal Articles
Files in This Item:
File Description SizeFormat 
3595-Published Article Text-18207-1-10-20191130.pdf411.65 kBAdobe PDFView/Open
Show simple item record

Page view(s)

92
checked on May 5, 2024

Download(s)

20
checked on May 5, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.